+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Mexico Veterinary Medicine Market Size, Share & Trends Analysis Report by Animal Type (Production Animals, Companion Animals), Product, Route of Administration (Oral, Injectable, Topical), Distribution Channel with Growth Forecasts, 2025-2030

  • PDF Icon

    Report

  • 150 Pages
  • February 2025
  • Region: Mexico
  • Grand View Research
  • ID: 6056019
The Mexico Veterinary Medicine Market was valued at USD 1.65 billion in 2024, and is projected to reach USD 2.65 billion by 2030, rising at a CAGR of 8.37%. The primary drivers of market growth include the increasing consumption of meat and dairy products, initiatives undertaken by notable players, and technological advancements. Mexico's meat consumption is predicted to increase over the next ten years, according to USDA Agricultural Projections till 2033. In 2033, it is anticipated that Mexico will consume 82.5 kg of beef, pig, and poultry per person. From 38.3 kg per person in 2023 to 43.8 kg per person in 2033, poultry consumption is expected to rise the greatest.

The veterinary medicine market in Mexico is significantly influenced by the rising R&D activities and strategic initiatives undertaken by key players in the industry. Tailored marketing campaigns and distribution agreements help key players ensure the availability of veterinary products across rural and urban areas. For instance, in May 2024, At the World Buiatrics Congress 2024, which took place in Cancun, Mexico between May 20 to 24, Merck & Co., Inc. presented its array of innovative techniques to improve ruminant health.

Government initiatives, such as the launch of a new Veterinary Pharmacovigilance System, play a crucial role in enhancing the safety, quality, and efficacy of animal medications. In Mexico, such initiatives can significantly impact the Mexico veterinary medicine market by creating new opportunities. For instance, in August 2024, to improve the efficacy, safety, and quality of animal pharmaceuticals, the Ministry of Agriculture and Rural Development has introduced a new Veterinary Pharmacovigilance System. The National Service for Health, Safety, and Agri-Food Quality (SENASICA) created the system with the aim of identifying, evaluating, and reducing risks related to veterinary medications that are supplied in Mexico. The General Directorate of Animal Health oversees the system, which gathers information from administrators of veterinary products in order to track and stop animal adverse responses during the drug administration process. This program aims to guarantee the production of healthy and secure food and encourage the safe use of veterinary medications.

Moreover, the high costs associated with animal healthcare indeed pose a challenge to the growth of the Mexico veterinary medicine market in Mexico. Veterinary treatments, particularly for chronic conditions, surgeries, or advanced diagnostic procedures, can be prohibitively expensive. According to an article published by Ours Abroad LLC in November 2024, President Claudia Sheinbaum has addressed about the excessive veterinary expenses that Mexican pet owners have to bear, which forces them to make tough choices about their pets' care. The typical consultation costs between 300 and 800 pesos, which is a major financial burden for many families, according to reporter Gustavo García. This excessive expense frequently results in circumstances when pet owners are unable to pay for the required care, and in extreme cases, are compelled to sacrifice their animals for lack of funds.

Mexico Veterinary Medicine Market Report Highlights

  • Based on product, pharmaceuticals held the dominant share of the market in 2024. Market expansion is driven by rising demand for potent drugs as a result of the increasing incidence of various veterinary illnesses.
  • Based on animal type, production animals dominated the market in 2024. The chicken business has expanded dramatically in recent years due to the growing popularity of protein-based foods.
  • Based on route of administration, injectable segment dominated the market in 2024. Other route of administration is anticipated to grow at the fastest CAGR over the forecast period.
  • Based on distribution channel, the veterinary hospitals & clinics segment dominated the market in 2024. This can be attributed to the expansion of 24/7 veterinary hospitals, such as Mosaic Animal Emergency and Specialty in Mexico.

This report addresses:

  • Market intelligence to enable effective decision-making.
  • Market estimates and forecasts from 2018 to 2030.
  • Growth opportunities and trend analyses.
  • Segment and regional revenue forecasts for market assessment.
  • Competition strategy and market share analysis.
  • Product innovation listings for you to stay ahead of the curve.
  • COVID-19's impact and how to sustain in this fast-evolving market.

Why Should You Buy This Report?

  • Comprehensive Market Analysis: Gain detailed insights into the market across major regions and segments.
  • Competitive Landscape: Explore the market presence of key players.
  • Future Trends: Discover the pivotal trends and drivers shaping the future of the market.
  • Actionable Recommendations: Utilize insights to uncover new revenue streams and guide strategic business decisions.

Table of Contents

Chapter 1 Methodology And Scope
1.1 Market Segmentation And Scope
1.1.1 Regional Scope
1.1.2 Estimates And Forecast Timeline
1.2 Research Methodology
1.3 Information Procurement
1.3.1 Purchased Database:
1.3.2 Internal Database
1.3.3 Secondary Sources
1.3.4 Primary Research
1.4 Information/Data Analysis
1.4.1 Information Analysis
1.5 Market Formulation & Visualization
1.6 Data Validation & Publishing
1.7 Model Details
1.7.1 Approach 1: Commodity Flow Analysis
1.7.1.1 Hybrid Market Estimation Model
1.7.2 Country Market: Cagr Calculation
1.7.3 Approach 2: Parent Market Analysis
1.8 List Of Secondary Sources
Chapter 2 Executive Summary
2.1 Market Snapshot
2.2 Product & Animal Segment Snapshot
2.3 Route Of Administration & Distribution Channel Segment Snapshot
2.4 Competitive Landscape Snapshot
Chapter 3 Mexico Veterinary Medicine Market: Variables, Trends & Scope
3.1 Market Lineage Outlook
3.1.1 Parent Market Outlook
3.1.2 Ancillary Market Analysis
3.2 Mexico Veterinary Medicine Market Dynamics
3.2.1 Market Driver Impact Analysis
3.2.1.1 Rise In Livestock Population And Increasing Pet Ownership Rates
3.2.1.2 Increasing Number Of Zoonotic & Chronic Diseases
3.2.1.3 Rising R&D And Strategic Initiatives By Key Players
3.2.1.4 Increasing Consumption Of Meat And Dairy Products
3.2.2 Market Restraint Impact Analysis
3.2.2.1 Government Intervention
3.2.2.2 Increasing Influx Of Counterfeit Drugs
3.2.2.3 High Cost Associated With Animal Healthcare
3.2.3 Market Opportunity Analysis
3.2.4 Market Challenge Analysis
3.3 Mexico Veterinary Medicine Market: Porter’s 5 Forces Analysis
3.3.1 Bargaining Power Of Suppliers: Low
3.3.2 Bargaining Power Of Buyers: Moderate
3.3.3 Threat Of Substitutes: Moderate
3.3.4 Threat Of New Entrants: Low
3.3.5 Competitive Rivalry: High
3.4 Mexico Veterinary Medicine Market: Pestel Analysis
3.4.1 Political & Legal Landscape
3.4.2 Economic & Social Landscape
3.4.3 Technology Landscape
3.4.4 Environmental Landscape
3.5 Regulatory Framework
3.6 Estimated Animal Population By Key Species, 2018-2024
3.7 User Perspective Analysis
3.7.1 Pet Owners:
3.7.2 Veterinarians:
3.7.3 Pharmaceutical Companies:
3.7.4 Regulatory Bodies:
3.7.5 Retailers And Distributors:
3.7.6 Agricultural Sector:
3.8 COVID-19 Impact Analysis
Chapter 4 Animal Type Estimates & Trend Analysis, 2018-2030 (USD Million)
4.1 Mexico Veterinary Medicine Market By Animal Type: Key Takeaways
4.2 Animal Type Movement Analysis & Market Share, 2024 & 2030
4.3 Mexico Veterinary Medicine Market Estimates & Forecast, by Animal Type (USD Million)
4.4 Production Animals
4.4.1 Production Animals Market Estimates And Forecasts, 2018-2030 (USD Million)
4.4.2 Poultry
4.4.2.1 Poultry Market Estimates And Forecasts, 2018-2030 (USD Million)
4.4.3 Pigs
4.4.3.1 Pigs Market Estimates And Forecasts, 2018-2030 (USD Million)
4.4.4 Cattle
4.4.4.1 Cattle Market Estimates And Forecasts, 2018-2030 (USD Million)
4.4.5 Sheep & Goats
4.4.5.1 Sheep & Goats Market Estimates And Forecasts, 2018-2030 (USD Million)
4.4.6 Others
4.4.6.1 Others Market Estimates And Forecasts, 2018-2030 (USD Million)
4.5 Companion Animals
4.5.1 Companion Animals Market Estimates And Forecasts, 2018-2030 (USD Million)
4.5.2 Dogs
4.5.2.1 Dogs Market Estimates And Forecasts, 2018-2030 (USD Million)
4.5.3 Cats
4.5.3.1 Cats Market Estimates And Forecasts, 2018-2030 (USD Million)
4.5.4 Horses
4.5.4.1 Horses Market Estimates And Forecasts, 2018-2030 (USD Million)
4.5.5 Others
4.5.5.1 Others Market Estimates And Forecasts, 2018-2030 (USD Million)
Chapter 5 Product Estimates & Trend Analysis, 2018-2030 (USD Million)
5.1 Mexico Veterinary Medicine Market By Product: Key Takeaways
5.2 Product Movement Analysis & Market Share, 2024 & 2030
5.3 Mexico Veterinary Medicine Market Estimates & Forecast, by Product (USD Million)
5.4 Biologics
5.4.1 Biologics Market Estimates And Forecasts, 2018-2030 (USD Million)
5.4.2 Vaccine
5.4.2.1 Vaccine Market Estimates And Forecasts, 2018-2030 (USD Million)
5.4.2.2 Modified/ Attenuated Live
5.4.2.2.1 Modified/ Attenuated Live Market Estimates And Forecasts, 2018-2030 (USD Million)
5.4.2.3 Inactivated (Killed)
5.4.2.3.1 Inactivated (Killed) Market Estimates And Forecasts, 2018-2030 (USD Million)
5.4.2.4 Other Vaccines
5.4.2.4.1 Other Vaccines Market Estimates And Forecasts, 2018-2030 (USD Million)
5.4.3 Others
5.4.3.1 Others market estimates and Forecasts, 2018-2030 (USD Million)
5.5 Pharmaceuticals
5.5.1 Pharmaceuticals Market Estimates And Forecasts, 2018-2030 (USD Million)
5.5.2 Parasiticides
5.5.2.1 Parasiticides Market Estimates And Forecasts, 2018-2030 (USD Million)
5.5.3 Anti-Infectives
5.5.3.1 Anti-Infectives Market Estimates And Forecasts, 2018-2030 (USD Million)
5.5.4 Anti-Inflammatory
5.5.4.1 Anti-Inflammatory Market Estimates And Forecasts, 2018-2030 (USD Million)
5.5.5 Analgesics
5.5.5.1 Analgesics market estimates and Forecasts, 2018-2030 (USD Million)
5.5.6 Others
5.5.6.1 Others Market Estimates And Forecasts, 2018-2030 (USD Million)
5.6 Medicated Feed Additives
5.6.1 Medicated Feed Additives Market Estimates And Forecasts, 2018-2030 (USD Million)
Chapter 6 Route Of Administration Estimates & Trend Analysis, 2018-2030 (USD Million)
6.1 Mexico Veterinary Medicine Market By Route Of Administration: Key Takeaways
6.2 Route Of Administration Movement Analysis & Market Share, 2024 & 2030
6.3 Mexico Veterinary Medicine Market Estimates & Forecast, by Route Of Administration (USD Million)
6.4 Oral
6.4.1 Oral Market Estimates And Forecasts, 2018-2030 (USD Million)
6.5 Injectable
6.5.1 Injectable Market Estimates And Forecasts, 2018-2030 (USD Million)
6.6 Topical
6.6.1 Topical Market Estimates And Forecasts, 2018-2030 (USD Million)
6.7 Others
6.7.1 Others Market Estimates And Forecasts, 2018-2030 (USD Million)
Chapter 7 Distribution Channel Estimates & Trend Analysis, 2018-2030 (USD Million)
7.1 Mexico Veterinary Medicine Market By Distribution Channel: Key Takeaways
7.2 Distribution Channel Movement Analysis & Market Share, 2024 & 2030
7.3 Mexico Veterinary Medicine Market Estimates & Forecast By Distribution Channel (USD Million)
7.4 Veterinary Hospitals & Clinics
7.4.1 Veterinary Hospitals & Clinics Market Estimates And Forecasts, 2018-2030 (USD Million)
7.5 E-Commerce
7.5.1 E-Commerce Market Estimates And Forecasts, 2018-2030 (USD Million)
7.6 Offline Retail Stores
7.6.1 Offline Retail Stores Market Estimates And Forecasts, 2018-2030 (USD Million)
7.7 Others
7.7.1 Others Market Estimates And Forecasts, 2018-2030 (USD Million)
Chapter 8 Competitive Landscape
8.1 Participants Overview
8.2 Financial Performance
8.3 Market Share Analysis, by Key Players, 2024
8.4 Product Benchmarking
8.5 Market Participant Categorization
8.6 Market Position Analysis, 2024 (Heat Map Analysis)
8.7 Strategy Mapping
8.7.1 Mergers And Acquisitions
8.7.2 Product Launch/Product Approval
8.7.3 Partnerships & Collaborations
8.7.4 Expansion
8.7.5 Others
8.8 List of Key Market Players
8.8.1 Zoetis Inc.
8.8.1 Boehringer Ingelheim International GmbH
8.8.1 Merck & Co., Inc.
8.8.1 Elanco
8.8.1 Dechra Pharmaceuticals PLC
8.8.1 Ceva Santé Animale
8.8.1 Phibro Animal Health Corporation
8.8.1 Virbac
8.8.1 Bimeda Corporate
8.8.1 Biogénesis Bagó
8.8.1 Ourofino Saude Animal
Chapter 9 Key Takeaways
List of Tables
Table 1 List of secondary sources
Table 2 Estimated animal population in Mexico, by key species, 2018 to 2024
Table 3 Mexico Veterinary Medicine Market estimates and forecast, by animal type, 2018-2030 (USD Million)
Table 4 Mexico Veterinary Medicine Market estimates and forecast, by production animal, 2018-2030 (USD Million)
Table 5 Mexico Veterinary Medicine Market estimates and forecast, by companion animals, 2018-2030 (USD Million)
Table 6 Mexico veterinary medicine market estimates and forecast, by product, 2018-2030 (USD Million)
Table 7 Mexico veterinary medicine market estimates and forecast, by biologics, 2018-2030 (USD Million)
Table 8 Mexico veterinary medicine market estimates and forecast, by vaccines, 2018-2030 (USD Million)
Table 9 Mexico veterinary medicine market estimates and forecast, by pharmaceuticals, 2018-2030 (USD Million)
Table 10 Mexico veterinary medicine market estimates and forecast, by route of administration, 2018-2030 (USD Million)
Table 11 Mexico veterinary medicine market estimates and forecast, by route of administration, 2018-2030 (USD Million)
Table 12 Participants' overview
Table 13 Financial performance
Table 14 Market Share Analysis, by Key Players, 2024
Table 15 Key companies initiating mergers & acquisitions.
Table 16 Key companies launching new products and getting approvals.
Table 17 Key companies undertaking partnership & collaboration strategies
Table 18 Key companies initiating expansion strategies
Table 19 Key companies undertaking other strategic initiatives
List of Figures
Figure 1 Mexico veterinary medicine market segmentation
Figure 2 Market research process
Figure 3 Information procurement
Figure 4 Primary research pattern
Figure 5 Data Analysis Models
Figure 6 Market Formulation And Validation
Figure 7 Data Validating & Publishing
Figure 8 General methodology for commodity flow analysis of Mexico veterinary medicine market
Figure 9 Commodity flow analysis
Figure 10 Parent market analysis
Figure 11 Market snapshot
Figure 12 Product & animal segment snapshot
Figure 13 Route of administration & distribution channel segment snapshot
Figure 14 Competitive landscape snapshot
Figure 15 Parent Market Analysis, 2024 (USD Billion)
Figure 16 Ancillary Market Outlook, 2024
Figure 17 Mexico Veterinary Medicine Market Dynamics
Figure 18 Mexico Veterinary Medicine Market: PORTER’s Analysis
Figure 19 Mexico Veterinary Medicine Market PESTEL Analysis
Figure 20 Mexico veterinary medicine market by animal type: Key takeaways
Figure 21 Mexico veterinary medicine market by animal type, market share, 2024 & 2030
Figure 22 Production animals market, 2018-2030 (USD Million)
Figure 23 Poultry market, 2018-2030 (USD Million)
Figure 24 Pigs market, 2018-2030 (USD Million)
Figure 25 Cattle market, 2018-2030 (USD Million)
Figure 26 Sheep & Goats market, 2018-2030 (USD Million)
Figure 27 Others market, 2018-2030 (USD Million)
Figure 28 Companion animals market, 2018-2030 (USD Million)
Figure 29 Dogs market, 2018-2030 (USD Million)
Figure 30 Cats market, 2018-2030 (USD Million)
Figure 31 Horses market, 2018-2030 (USD Million)
Figure 32 Others market, 2018-2030 (USD Million)
Figure 33 Mexico veterinary medicine market by product: Key takeaways
Figure 34 Mexico veterinary medicine market by product, market share, 2024 & 2030
Figure 35 Biologics market, 2018-2030 (USD Million)
Figure 36 Vaccine market, 2018-2030 (USD Million)
Figure 37 Modified/attenuated live market, 2018-2030 (USD Million)
Figure 38 Inactivated (killed) market, 2018-2030 (USD Million)
Figure 39 Other vaccines market, 2018-2030 (USD Million)
Figure 40 Others market, 2018-2030 (USD Million)
Figure 41 Pharmaceuticals market, 2018-2030 (USD Million)
Figure 42 Parasiticides market, 2018-2030 (USD Million)
Figure 43 Anti-infectives market, 2018-2030 (USD Million)
Figure 44 Anti-inflammatory market, 2018-2030 (USD Million)
Figure 45 Analgesics market, 2018-2030 (USD Million)
Figure 46 Others market, 2018-2030 (USD Million)
Figure 47 Medicated feed additives market, 2018-2030 (USD Million)
Figure 48 Mexico veterinary medicine market by route of administration: Key takeaways
Figure 49 Mexico veterinary medicine market by route of administration, market share, 2024 & 2030
Figure 50 Oral market, 2018-2030 (USD Million)
Figure 51 Injectable market, 2018-2030 (USD Million)
Figure 52 Topical market, 2018-2030 (USD Million)
Figure 53 Others market, 2018-2030 (USD Million)
Figure 54 Mexico veterinary medicine market by distribution channel: Key takeaways
Figure 55 Mexico veterinary medicine market by distribution channel, market share, 2024 & 2030
Figure 56 Veterinary hospitals & clinics market, 2018-2030 (USD Million)
Figure 57 E-commerce market, 2018-2030 (USD Million)
Figure 58 Offline retail stores market, 2018-2030 (USD Million)
Figure 59 Others market, 2018-2030 (USD Million)
Figure 60 Market participant categorization
Figure 61 Heat map analysis
Figure 62 Strategic Framework

Companies Mentioned

The major companies profiled in this Mexico Veterinary Medicine market report include:
  • Zoetis Inc.
  • Boehringer Ingelheim International Gmbh
  • Merck & Co., Inc.
  • Elanco
  • Dechra Pharmaceuticals PLC
  • Ceva Santé Animale
  • Phibro Animal Health Corporation
  • Virbac
  • Bimeda Corporate
  • Biogénesis Bagó
  • Ourofino Saude Animal

Methodology

Loading
LOADING...

Table Information